PET-scans
Quantification of amyloid PET scans in early detection of Alzheimer’s disease
35
Classification of Alzheimer’s Disease in PET Scans using MFCC and SVM
7
Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?
8
Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease
9
Guidelines for quality control of PET/CT scans in a multicenter clinical study
15
The role of positron emission tomography in the management of colorectal cancer
280
Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?
7
UNERTAN SYNDROME: A CASE SERIES DEMONSTRTAING HUMAN DEVOLUTION
20
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport
13
Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas
9
Impact of MR-safe headphones on PET attenuation in combined PET/MRI scans
5
Functional imaging of dolphin brain metabolism and blood flow
9
Granulomatous Diseases Should be Considered in Mediastinal Lymphadenopathies with High F-18 FDG Uptake on PET-CT Scans
6
First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors
12
18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis
10
Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell Cancer
5
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
11
18F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats
10
Extrapulmonary small cell sarcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans
5
Designing a new molecular probe : the potential role for Tilmanocept (Lymphoseek) in the assessment of patients with painful hip and knee joint prostheses
14